JPRN-UMIN000024442未知4 期
Comparison of fesoterodine and mirabegron in the treatment of female overactive baldder patients with urgency incontinence: A randomized, prospective study (Feminine study) - Feminine study
Department of urology, Nagoya University Graduate School of Medicine0 个研究点目标入组 300 人开始时间: 2016年11月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patients were excluded if they received oral anticholinergic agents, alpha1-blockers, antidepressants, or anti-anxiety agents, had obvious neurogenic bladder dysfunction, bladder calculi, or active urinary tract infection, or had severe cardiac disease, renal dysfunction (serum-creatinine >2 mg/dL), and/or hepatic dysfunction (i.e., aspartate aminotransferase and alanine aminotransferase levels of more than twice the normal value)
研究者
相似试验
尚未招募
4 期
A comparison of medicines used for overactive bladder (fesoterodine vs mirabegron vs solifenacin)CTRI/2024/02/063069VYOMA DESAI
尚未招募
不适用
Prospective comparison of mirabegron and fesoterodine for overactive bladderOveractive bladder(OAB)JPRN-UMIN000045947agasaki University Hospital Department of urology140
已完成
不适用
Comparison of Mirabegron and Imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT Study).Overactive bladderJPRN-UMIN000010321Department of Urology, Hamamatsu University School of Medicine200
尚未招募
不适用
Add on Effect of Fesoterodine and Vibegron for Male Overactive Bladder Treated with Tadalafil Multicenter Randomized Comparative Studyoveractive bladderJPRN-UMIN000038483Department of Renal and Urologic Surgery, Asahikawa Medical University280
尚未招募
4 期
Comparing the efficacy of Mirabegron in reducing urinary symptoms associated with cerebrovascular accidentsCTRI/2023/03/050511DEPARTMENT OF UROLOGY KASTURBA MEDICAL COLLEGE MANIPA